Get Bristol Myers Squibb Direct Reimbursement Claim Form

The BMS Oncology Co-pay Assistance Program helps commercially insured patients who have been prescribed select BMS medications with out-of-pocket deductibles, co-pays, or co-insurance requirements. Eligible patients may pay as little as $0 per infusion, up to a maximum of $10,000 per calendar year. Restrictions apply.

Bristol Myers becomes a publicly held firm on the New York Stock Exchange.

Bristol-Myers Squibb Company, American biopharmaceutical company resulting from a merger in 1989 and dating to companies founded in 1858 and 1887. It produces pharmaceuticals, vitamins, medical devices, and beauty and personal-care products. Headquarters are in New York City.

Syracuse, N.Y. -- South Korean conglomerate Lotte has completed its $160 million purchase of Bristol Myers Squibb's pharmaceutical plant in East Syracuse.

Bristol-Myers Squibb's $74 billion acquisition of Celgene would combine two troubled companies. Bristol Myers-Squibb is acquiring Celgene in a cash and stock deal valued at $74 billion. Bristol Myers-Squibb's immuno-oncology drug Opdivo has struggled to keep up with Merck's Keytruda. Celgene has faced its own problems.

Bristol-Myers Squibb is not owned by hedge funds. Our data shows that The Vanguard Group, Inc. is the largest shareholder with 9.0% of shares outstanding. With 7.8% and 4.2% of the shares outstanding respectively, BlackRock, Inc.

You have a yearly income of less than ~250% of the Federal Poverty Level: $28,725 or less for a single person. $38,775 or less for a family size of two. Larger family sizes are adjusted ingly. Medications that are injected may be subject to higher limits.

For more information, call BMS Access Support at 1-800-861-0048, 8 am to 8 pm ET, Monday - Friday. The accurate completion of reimbursement- or coverage-related documentation is the responsibility of the healthcare provider and patient.